Helicobacter pylori (H. pylori) Infection-Associated Dyslipidemia in the Asir Region of Saudi Arabia
Author:
Izhari Mohammad Asrar1, Al Mutawa Omar A.1, Mahzari Ali1ORCID, Alotaibi Essa Ajmi2, Almashary Maher A.3, Alshahrani Jaber Abdullah4, Gosady Ahmed R. A.5, Almutairi Abdulrahman M6, Dardari Daifallah M. M.7, AlGarni Abdul Kareem A.8
Affiliation:
1. Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al Baha 65522, Saudi Arabia 2. Department of Dermatology, Al-Kharj Military Hospital, Al-Kharj 11361, Saudi Arabia 3. Medical Services Department, Armed Forces Medical Services, Riyadh 11159, Saudi Arabia 4. Department of Medical Training and Education, Armed Forces Hospital Southern Region, Khamis Mushait 62413, Saudi Arabia 5. Laboratory Department, Baish Primary Healthcare, Jazan 87311, Saudi Arabia 6. Health facilities Infection Control Department, General Directorate of Health, Al-Baha 11134, Saudi Arabia 7. Laboratory Department, Baish General Hospital, Jazan 87732, Saudi Arabia 8. Department of Hematology, King Saud Bin Abdulaziz University for Health Sciences, Al-Ahsa 11451, Saudi Arabia
Abstract
Objectives: H. pylori-associated dyslipidemia has been reported to be a major risk factor for atherosclerosis and coronary heart diseases. We aimed to investigate the association of the H. pylori infection with dyslipidemia. Methods: A retrospective case–control study was undertaken to evaluate H. pylori-associated dyslipidemia, where H. pylori-positive individuals were treated as the case group (n = 260) while H. pylori-negative individuals were considered as the control group (n = 250). The mean ± SD of the age of the patients included (n = 510) was 44.01 ± 13.58 years. Study subjects with a total cholesterol level of >5.17 mmol/L and/or a triglyceride level of >1.69 mmol/L and/or an LDL-C level of >2.59 mmol/L and/or an HDL-C level of <1 mmol/L in males and/or an HDL-C level of <1.3 mmol/L in females were defined as dyslipidemia. Descriptive (mean, standard deviation, median, and IQR) and inferential (t-test, chi-square test, and logistic regression) statistical analyses were undertaken using the R-base/R-studio (v-4.0.2)/tidyverse package. Univariate and bivariate logistic regressions were executed to calculate the crude and adjusted odds ratio along with the p-value. A p-value of <0.05 was the cut-off for statistical significance. We used ggplot2 for data visualization. Results: The differences in overall mean ± SD (H. pylori positive vs. negative) of the cholesterol (5.22 ± 1.0 vs. 5.49 ± 0.85, p < 0.01), triglyceride (1.66 ± 0.75 vs. 1.29 ± 0.71, p < 0.001), LDL-C (3.43 ± 0.74 vs. 3.26 ± 0.81, p < 0.05), and HDL-C (1.15 ± 0.30 vs. 1.30 ± 0.25, p < 0.001) levels were statistically significant. The cholesterol and LDL-C levels in ages >60, age = 30–60, in females, and LDL-C levels in males were not significantly different for the H. pylori-positive and -negative groups. The proportion (H. pylori positive vs. negative) of hypercholesterolemia (190/59.9% vs. 127/40% p < 0.01), hypertriglyceridemia (136/68% vs. 64/32% p < 0.001), high LDL-cholesterolemia levels (234/53% vs. 201/46% p < 0.01), and low HDL-cholesterolemia levels (149/71% vs. 60/28.7% p < 0.01) were statistically significant. The odds of having hypercholesterolemia (AOR: 2.64, 95%CI: 1.824–3.848, p < 0.001), hypertriglyceridemia (AOR: 3.24, 95%CI: 2.227–4.757, p < 0.001), an increased LDL-C level (AOR: 2.174, 95%CI: 1.309–3.684, p < 0.01), and a decreased HDL-C level (AOR: 4.2, 95%CI: 2.937–6.321, p < 0.001) were 2.64, 3.24, 2.17, and 4.2 times higher in the H. pylori-infected individuals as compared with the H. pylori-uninfected group. Conclusion: Our results demonstrate that an enhanced risk of dyslipidemia is associated with the H. pylori infection, which can aggrandize the atherosclerosis process. The evaluation of temporal variation in the lipid profile in H. pylori-infected individuals is recommended for the effective management of H. pylori-infected patients.
Subject
Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics
Reference52 articles.
1. Helicobacter pylori: 10th anniversary of its culture in April 1982;Goodwin;Gut,1993 2. Helicobacter pylori y enfermedades extragástricas: Una revisión;Gravina;Rev. Mund. Gastroenterol.,2018 3. Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis;Hooi;Gastroenterology,2017 4. Molecular characterization of Helicobacter pylori clinical isolates from Eastern Saudi Arabia;Alkharsah;Saudi Med. J.,2022 5. Helicobacter pylori infection among dyspepsia patients in suburbs of Riyadh, Saudi Arabia;Alghamdi;J. Pak. Med. Assoc.,2020
|
|